Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Empagliflozin (25mg) Tablet
Therapeutic Category
Antidiabetic, Cardiovascular, Endocrinology
Dosage Form
Tablet
Packaging Type
Blister
Packaging
10*10
Price
₹600/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Emplozin 25 Tablet is an antidiabetic medication belonging to the class of Sodium-Glucose Co-Transporter-2 (SGLT2) inhibitors. It is used to manage blood sugar levels in individuals with type 2 diabetes mellitus, particularly when diet and exercise alone are insufficient. By reducing glucose reabsorption in the kidneys, it promotes glucose excretion through urine, helping maintain optimal blood sugar levels. Additionally, Empagliflozin has shown cardiovascular benefits, including reducing the risk of cardiovascular death in patients with type 2 diabetes and established heart disease.
This medication supports better glycemic control, potentially leading to weight loss and lower blood pressure due to its unique mechanism of action. Emplozin 25 Tablet is an effective solution for managing diabetes and its complications under the guidance of a healthcare provider.
Common side effects include urinary tract infections, increased urination, dizziness, and dehydration. Rare but serious side effects include ketoacidosis and severe genital infections.
Emplozin 25 Tablet is indicated for the treatment of type 2 diabetes mellitus as an adjunct to diet and exercise. It also reduces the risk of cardiovascular death in patients with type 2 diabetes and cardiovascular disease.
This medication is not suitable for type 1 diabetes or diabetic ketoacidosis. Always follow the prescribed dosage and inform your doctor about any underlying conditions or medications you are taking.
Store in a cool, dry place at a temperature below 30°C. Protect from light and moisture. Keep out of reach of children.
Composition : Empagliflozin (10mg) Tablet
Composition : Empagliflozin (10mg) + Linagliptin (5mg)
Composition : Empagliflozin (25mg) + Linagliptin (5mg)
Composition : Empagliflozin (12.5mg) + Metformin (1000mg)
Composition : Empagliflozin (12.5mg) + Metformin (500mg)
Composition : Empagliflozin (5mg) + Metformin (500mg)
Composition : Empagliflozin (10mg) + Sitagliptin 100mg
Composition : Empagliflozin (25mg) + Sitagliptin (100mg) Tablet
Composition : Empagliflozin 10mg + Sitagliptin 100mg + Metformin 1000mg (extended release)
Composition : Empagliflozin 25mg + Sitagliptin 100mg + Metformin 1000mg (extended release)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Empagliflozin 25mg Tablet is a widely prescribed anti-diabetic medicine used in type 2 diabetes management, making it a high-demand prescription product for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma pharma franchise market.
Medical distributors and wholesalers can benefit from strong demand in type 2 diabetes, blood sugar control, cardiovascular risk reduction support, weight management support, and long-term glycemic control. It is commonly prescribed by diabetologists and physicians as part of modern diabetes therapy.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for Empagliflozin 25mg Tablet with monopoly rights, quality packaging, competitive pricing, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from strong chronic prescription demand, growing diabetic patient populations, repeat monthly therapy usage, and high acceptance in diabetology and general medicine segments when partnering with Cafoli Lifecare.
Medical distributors, stockists, wholesalers, and pharma professionals interested in this anti-diabetic formulation can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, pricing, and distribution support services.